Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 17, 2006New second-generation training center in Brussels to help medical professionals advance standard of patient care
Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in...
-
May 17, 2006TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
EuroIntervention, the peer-reviewed medical journal affiliated with the Paris Course on Revascularization, today released an integrated...
-
May 16, 2006TAXUS VI results support positive safety and efficacy profile
Boston Scientific Corporation (NYSE: BSX) today announced three-year follow-up data from its TAXUS VI clinical trial. The data...
-
May 16, 2006Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2™ stent system, even with more complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS ATLAS clinical trial. The results confirmed...
-
May 16, 2006
Boston Scientific Corporation (NYSE: BSX) today announced 12-month data from its MELODIE clinical trial. The trial demonstrates the...
-
May 16, 2006Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) announced today that it has received indication extensions to the European CE mark for its TAXUS®...
-
May 15, 2006
Boston Scientific Corporation (NYSE: BSX) today announced physician communications related to products in its Cardiac Rhythm Management (CRM) Group,...
-
May 11, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding two jury decisions in a...
-
May 11, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that Donald S. Baim, M.D., will be joining the Company as Executive Vice President, Chief...
-
May 10, 2006Boston Scientific is the exclusive U.S. distributor of this product for a new treatment option for female stress urinary incontinence
Boston Scientific Corporation (NYSE: BSX) and BioForm Medical, Inc. today announced United States Food and Drug Administration...